Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal

Title: Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal
Creator: Allsop, D.J.; Lintzeris, N.; Copeland, J.; Dunlop, A.; McGregor, I.S.
Relation: Clinical Pharmacology and Therapeutics Vol. 97, Issue 6, p. 571-574
Publisher Link: http://dx.doi.org/10.1002/cpt.109
Publisher: John Wiley & Sons
Resource Type: journal article
Date: 2015
Description: Cannabis is a common recreational drug that is generally considered to have low addictive potential. However, an increasing number of cannabis users are seeking treatment for dependence on the drug. There is interest in using agonist (substitution) pharmacotherapies to treat cannabis dependence and here we outline a novel approach involving a buccal spray (nabiximols) that contains tetrahydrocannabinol (THC) and cannabidiol (CBD). We review recent research with nabiximols and highlight findings relevant to clinical practice.
Subject: cannabis; cannabinoid Replacement Therapy; treatment; withdrawal
Identifier: http://hdl.handle.net/1959.13/1340223
Identifier: uon:28421
Identifier: ISSN:1532-6535
Language: eng
Reviewed

		Thumbnail	File	Description	Size	Format